{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:06:16Z","timestamp":1780131976306,"version":"3.54.0"},"reference-count":108,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:sec>\n                    <jats:title>Object<\/jats:title>\n                    <jats:p>The current treatment for recurrent or malignant meningiomas with adjuvant therapies has not been satisfactory, and there is an intense interest in evaluating new molecular markers to act as therapeutic targets. Enzymes of the arachidonic acid (AA) cascade such as cyclooxygenase (COX)\u20132 or 5-lipoxygenase (5-LO) are upregulated in a number of epithelial tumors, but to date there are hardly any data about the expression of these markers in meningiomas. To find possible targets for chemotherapeutic intervention, the authors evaluated the expression of AA derivatives at different molecular levels in meningiomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred and twenty-four meningioma surgical specimens and normal human cortical tissue samples were immunohistochemically and cytochemically stained for COX-2, COX-1, 5-LO, and prostaglandin E receptor 4 (PTGER4). In addition, Western blot and polymerase chain reaction (PCR) analyses were performed to detect the presence of eicosanoids in vivo and in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty (63%) of 95 benign meningiomas, 21 (88%) of 24 atypical meningiomas, all five malignant meningiomas, and all normal human cortex samples displayed high COX-2 immunoreactivity. All cultured specimens and IOMM-Lee cells stained positive for COX-2, COX-1, 5-LO, and PTGER4. The PCR analysis demonstrated no changes in eicosanoid expression among meningiomas of different World Health Organization grades and in normal human cortical and dura mater tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Eicosanoid derivatives COX-1, COX-2, 5-LO, and PTGER4 enzymes show a high universal expression in meningiomas but are not upregulated in normal human cortex and dura tissue. This finding of the ubiquitous presence of these enzymes in meningiomas offers an excellent baseline for testing upcoming chemotherapeutic treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/foc-07\/10\/e8","type":"journal-article","created":{"date-parts":[[2007,12,14]],"date-time":"2007-12-14T14:35:54Z","timestamp":1197642954000},"page":"E8","source":"Crossref","is-referenced-by-count":4,"title":["Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?"],"prefix":"10.3171","volume":"23","author":[{"given":"Christina","family":"Pfister","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Ritz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Pfrommer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Bornemann","sequence":"additional","affiliation":[{"name":"the Institute of Brain Research, University of T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos S.","family":"Tatagiba","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Roser","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-02300e8","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1172\/JCI118480","article-title":"Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling","volume":"97","author":"Avis","year":"1996"},{"key":"b2-02300e8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/86477","article-title":"COX-2 as a multifunctional neuronal modulator","volume":"7","author":"Bazan","year":"2001"},{"key":"b3-02300e8","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.89.19.9044","article-title":"Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family","volume":"89","author":"Boado","year":"1992"},{"key":"b4-02300e8","series-title":"Cancer Res","first-page":"7689","article-title":"Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase","volume":"61","author":"Bradbury","year":"2001"},{"key":"b5-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"35451","DOI":"10.1074\/jbc.M302474200","article-title":"Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor","volume":"278","author":"Buchanan","year":"2003"},{"key":"b6-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF00148394","article-title":"Arachidonic acid metabolic profiles in human meningiomas and gliomas","volume":"5","author":"Castelli","year":"1987"},{"key":"b7-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-005-9093-x","article-title":"Salvage chemotherapy with CPT-11 for recurrent meningioma","volume":"78","author":"Chamberlain","year":"2006"},{"key":"b8-02300e8","series-title":"Cancer Biol Ther","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4161\/cbt.3.1.726","article-title":"Glioma growth inhibition by selective COX-2 inhibitors via cyclooxygenase independent pathways: implications for therapy","volume":"3","author":"Cherukuri","year":"2004"},{"key":"b9-02300e8","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jnnp.47.6.579","article-title":"Production of prostaglandins and thromboxane by isolated cells from intracranial tumors","volume":"47","author":"Cooper","year":"1984"},{"key":"b10-02300e8","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbrc.2006.03.073","article-title":"IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer","volume":"343","author":"Cui","year":"2006"},{"key":"b11-02300e8","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-8993(00)02978-4","article-title":"Cyclooxygenase (COX)-1 expressing macrophages\/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression","volume":"885","author":"Deininger","year":"2000"},{"key":"b12-02300e8","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s004010051075","article-title":"Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo","volume":"98","author":"Deininger","year":"1999"},{"key":"b13-02300e8","series-title":"J Cell Biochem Suppl","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1097-4644(2000)77:34+<97::AID-JCB16>3.0.CO;2-Z","article-title":"COX-2 and colon cancer: Potential targets for chemoprevention","volume":"77","author":"Fournier","year":"2000"},{"key":"b14-02300e8","series-title":"J Neurooncol","first-page":"233","article-title":"A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content","volume":"10","author":"Gaetani","year":"1991"},{"key":"b15-02300e8","series-title":"Bull Rheum Dis","first-page":"1","article-title":"An update on specific COX-2 inhibitors: the COXIBs","volume":"50","author":"Gupta","year":"2001"},{"key":"b16-02300e8","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9440(10)64198-3","article-title":"5-lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue","volume":"161","author":"Hennig","year":"2002"},{"key":"b17-02300e8","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-04-4090","article-title":"5-lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions","volume":"65","author":"Hennig","year":"2005"},{"key":"b18-02300e8","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20050451","article-title":"Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain","volume":"391","author":"H\u00e9tu","year":"2005"},{"key":"b19-02300e8","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2174\/0929867003374282","article-title":"COX-2 in brain and spinal cord implications for therapeutic use","volume":"7","author":"Hoffmann","year":"2000"},{"key":"b20-02300e8","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","article-title":"Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis","volume":"26","author":"J\u00e4\u00e4skel\u00e4inen","year":"1986"},{"key":"b21-02300e8","series-title":"Prostaglandins Leukot Essent Fatty Acids","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.plefa.2005.10.005","article-title":"Aberrant expression of 5-lipoxygenase-activating protein (5-lOXAP) has prognostic and survival significance in patients with breast cancer","volume":"74","author":"Jiang","year":"2006"},{"key":"b22-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.1074\/jbc.M211021200","article-title":"Identification of two novel nuclear import sequences on the 5-lipoxygenase protein","volume":"278","author":"Jones","year":"2003"},{"key":"b23-02300e8","series-title":"Cancer Res","first-page":"1326","article-title":"Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor","volume":"60","author":"Kishi","year":"2000"},{"issue":"2 Suppl","key":"b24-02300e8","series-title":"Cancer Control","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/107327480200902S04","article-title":"Celecoxib: a specific COX-2 inhibitor with anticancer properties","volume":"9","author":"Koki","year":"2002"},{"key":"b25-02300e8","series-title":"Cancer Lett","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3835(98)00127-X","article-title":"Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors","volume":"132","author":"Kokoglu","year":"1998"},{"key":"b26-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00165657","article-title":"Chemotherapy for meningiomas","volume":"29","author":"Kyritsis","year":"1996"},{"key":"b27-02300e8","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2174\/0929867003374336","article-title":"Role of cyclooxygenases in angiogenesis","volume":"7","author":"Leahy","year":"2000"},{"key":"b28-02300e8","series-title":"Am J Clin Oncol","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/01.COC.0000074308.97198.D0","article-title":"Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade","volume":"26","author":"Lin","year":"2003"},{"key":"b29-02300e8","series-title":"Circ Res","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer","volume":"77","author":"Liu","year":"1995"},{"key":"b30-02300e8","series-title":"Annu Rev Pharmacol Toxicol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","article-title":"COX-2: a target for colon cancer prevention","volume":"42","author":"Marnett","year":"2002"},{"key":"b31-02300e8","series-title":"Cancer Res","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclo-oxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000"},{"key":"b32-02300e8","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s004010100373","article-title":"Expression of prostaglandin H synthase-2 in human brain tumors","volume":"102","author":"Matsuo","year":"2001"},{"key":"b33-02300e8","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1084\/jem.182.6.1683","article-title":"A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter","volume":"182","author":"Melillo","year":"1995"},{"key":"b34-02300e8","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jnci\/91.17.1501","article-title":"Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme","volume":"91","author":"Milas","year":"1999"},{"key":"b35-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985"},{"key":"b36-02300e8","series-title":"J Neurosurg","first-page":"897","article-title":"Meningioma recurrence","volume":"92","author":"Nakasu","year":"2000"},{"key":"b37-02300e8","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004"},{"key":"b38-02300e8","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/01.NEU.0000195096.43258.94","article-title":"Increased expression of 5-lipoxygenase in high-grade astrocytomas","volume":"58","author":"Nathoo","year":"2006"},{"key":"b39-02300e8","series-title":"J Neurooncol","first-page":"165","article-title":"Hydroxyurea chemotherapy for unresectable or residual meningioma","volume":"49","author":"Newton","year":"2001"},{"issue":"2 Suppl","key":"b40-02300e8","series-title":"Aliment Pharmacol Ther","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1046\/j.1365-2036.16.s2.8.x","article-title":"Review article: COX-2, prostanoids and colon cancer","volume":"16","author":"Ota","year":"2002"},{"key":"b41-02300e8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002"},{"key":"b42-02300e8","series-title":"Clin Cancer Res","first-page":"2998","article-title":"A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2","volume":"7","author":"Pyo","year":"2001"},{"key":"b43-02300e8","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.22441","article-title":"Celecoxib inhibits meningioma tumor growth in a mouse xenograft model","volume":"109","author":"Ragel","year":"2007"},{"key":"b44-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3171\/jns.2005.103.3.0508","article-title":"Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application","volume":"103","author":"Ragel","year":"2005"},{"key":"b45-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3171\/jns.1997.86.5.0840","article-title":"Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea","volume":"86","author":"Schrell","year":"1997"},{"key":"b46-02300e8","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1158\/0008-5472.CAN-05-0220","article-title":"Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels","volume":"65","author":"Shin","year":"2005"},{"key":"b47-02300e8","series-title":"Nature","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992"},{"issue":"2 Suppl","key":"b48-02300e8","series-title":"Biomed Pharmacother","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1016\/S0753-3322(05)80044-7","article-title":"COX-2 inhibitors act as radiosensitizer in tumor treatment","volume":"59","author":"Sminia","year":"2005"},{"key":"b49-02300e8","series-title":"World J Gastroenterol","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.3748\/wjg.v12.i39.6355","article-title":"Expression of 5-lipoxygenase in human colorectal cancer","volume":"12","author":"Soumaoro","year":"2006"},{"key":"b50-02300e8","series-title":"Cell","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995"},{"key":"b51-02300e8","series-title":"World J Gastroenterol","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3748\/wjg.v9.i9.1990","article-title":"Role of COX-2 in carcino-genesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis","volume":"9","author":"Wu","year":"2003"},{"key":"b52-02300e8","series-title":"Neuron","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993"},{"key":"b53-02300e8","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L","article-title":"Recurrence of meningiomas","volume":"89","author":"Yamasaki","year":"2000"},{"key":"b54-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1074\/jbc.270.19.11463","article-title":"Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6","volume":"270","author":"Yan","year":"1995"},{"key":"b1-02300e8","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1172\/JCI118480","article-title":"Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling","volume":"97","author":"Avis","year":"1996"},{"key":"b2-02300e8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/86477","article-title":"COX-2 as a multifunctional neuronal modulator","volume":"7","author":"Bazan","year":"2001"},{"key":"b3-02300e8","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.89.19.9044","article-title":"Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family","volume":"89","author":"Boado","year":"1992"},{"key":"b4-02300e8","series-title":"Cancer Res","first-page":"7689","article-title":"Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase","volume":"61","author":"Bradbury","year":"2001"},{"key":"b5-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"35451","DOI":"10.1074\/jbc.M302474200","article-title":"Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor","volume":"278","author":"Buchanan","year":"2003"},{"key":"b6-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF00148394","article-title":"Arachidonic acid metabolic profiles in human meningiomas and gliomas","volume":"5","author":"Castelli","year":"1987"},{"key":"b7-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-005-9093-x","article-title":"Salvage chemotherapy with CPT-11 for recurrent meningioma","volume":"78","author":"Chamberlain","year":"2006"},{"key":"b8-02300e8","series-title":"Cancer Biol Ther","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4161\/cbt.3.1.726","article-title":"Glioma growth inhibition by selective COX-2 inhibitors via cyclooxygenase independent pathways: implications for therapy","volume":"3","author":"Cherukuri","year":"2004"},{"key":"b9-02300e8","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jnnp.47.6.579","article-title":"Production of prostaglandins and thromboxane by isolated cells from intracranial tumors","volume":"47","author":"Cooper","year":"1984"},{"key":"b10-02300e8","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbrc.2006.03.073","article-title":"IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer","volume":"343","author":"Cui","year":"2006"},{"key":"b11-02300e8","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-8993(00)02978-4","article-title":"Cyclooxygenase (COX)-1 expressing macrophages\/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression","volume":"885","author":"Deininger","year":"2000"},{"key":"b12-02300e8","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s004010051075","article-title":"Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo","volume":"98","author":"Deininger","year":"1999"},{"key":"b13-02300e8","series-title":"J Cell Biochem Suppl","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1097-4644(2000)77:34+<97::AID-JCB16>3.0.CO;2-Z","article-title":"COX-2 and colon cancer: Potential targets for chemoprevention","volume":"77","author":"Fournier","year":"2000"},{"key":"b14-02300e8","series-title":"J Neurooncol","first-page":"233","article-title":"A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content","volume":"10","author":"Gaetani","year":"1991"},{"key":"b15-02300e8","series-title":"Bull Rheum Dis","first-page":"1","article-title":"An update on specific COX-2 inhibitors: the COXIBs","volume":"50","author":"Gupta","year":"2001"},{"key":"b16-02300e8","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9440(10)64198-3","article-title":"5-lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue","volume":"161","author":"Hennig","year":"2002"},{"key":"b17-02300e8","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-04-4090","article-title":"5-lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions","volume":"65","author":"Hennig","year":"2005"},{"key":"b18-02300e8","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20050451","article-title":"Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain","volume":"391","author":"H\u00e9tu","year":"2005"},{"key":"b19-02300e8","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2174\/0929867003374282","article-title":"COX-2 in brain and spinal cord implications for therapeutic use","volume":"7","author":"Hoffmann","year":"2000"},{"key":"b20-02300e8","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","article-title":"Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis","volume":"26","author":"J\u00e4\u00e4skel\u00e4inen","year":"1986"},{"key":"b21-02300e8","series-title":"Prostaglandins Leukot Essent Fatty Acids","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.plefa.2005.10.005","article-title":"Aberrant expression of 5-lipoxygenase-activating protein (5-lOXAP) has prognostic and survival significance in patients with breast cancer","volume":"74","author":"Jiang","year":"2006"},{"key":"b22-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.1074\/jbc.M211021200","article-title":"Identification of two novel nuclear import sequences on the 5-lipoxygenase protein","volume":"278","author":"Jones","year":"2003"},{"key":"b23-02300e8","series-title":"Cancer Res","first-page":"1326","article-title":"Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor","volume":"60","author":"Kishi","year":"2000"},{"issue":"2 Suppl","key":"b24-02300e8","series-title":"Cancer Control","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/107327480200902S04","article-title":"Celecoxib: a specific COX-2 inhibitor with anticancer properties","volume":"9","author":"Koki","year":"2002"},{"key":"b25-02300e8","series-title":"Cancer Lett","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-3835(98)00127-X","article-title":"Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors","volume":"132","author":"Kokoglu","year":"1998"},{"key":"b26-02300e8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00165657","article-title":"Chemotherapy for meningiomas","volume":"29","author":"Kyritsis","year":"1996"},{"key":"b27-02300e8","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2174\/0929867003374336","article-title":"Role of cyclooxygenases in angiogenesis","volume":"7","author":"Leahy","year":"2000"},{"key":"b28-02300e8","series-title":"Am J Clin Oncol","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/01.COC.0000074308.97198.D0","article-title":"Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade","volume":"26","author":"Lin","year":"2003"},{"key":"b29-02300e8","series-title":"Circ Res","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer","volume":"77","author":"Liu","year":"1995"},{"key":"b30-02300e8","series-title":"Annu Rev Pharmacol Toxicol","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","article-title":"COX-2: a target for colon cancer prevention","volume":"42","author":"Marnett","year":"2002"},{"key":"b31-02300e8","series-title":"Cancer Res","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclo-oxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000"},{"key":"b32-02300e8","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s004010100373","article-title":"Expression of prostaglandin H synthase-2 in human brain tumors","volume":"102","author":"Matsuo","year":"2001"},{"key":"b33-02300e8","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1084\/jem.182.6.1683","article-title":"A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter","volume":"182","author":"Melillo","year":"1995"},{"key":"b34-02300e8","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jnci\/91.17.1501","article-title":"Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme","volume":"91","author":"Milas","year":"1999"},{"key":"b35-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","article-title":"Meningioma: analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff","year":"1985"},{"key":"b36-02300e8","series-title":"J Neurosurg","first-page":"897","article-title":"Meningioma recurrence","volume":"92","author":"Nakasu","year":"2000"},{"key":"b37-02300e8","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004"},{"key":"b38-02300e8","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/01.NEU.0000195096.43258.94","article-title":"Increased expression of 5-lipoxygenase in high-grade astrocytomas","volume":"58","author":"Nathoo","year":"2006"},{"key":"b39-02300e8","series-title":"J Neurooncol","first-page":"165","article-title":"Hydroxyurea chemotherapy for unresectable or residual meningioma","volume":"49","author":"Newton","year":"2001"},{"issue":"2 Suppl","key":"b40-02300e8","series-title":"Aliment Pharmacol Ther","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1046\/j.1365-2036.16.s2.8.x","article-title":"Review article: COX-2, prostanoids and colon cancer","volume":"16","author":"Ota","year":"2002"},{"key":"b41-02300e8","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002"},{"key":"b42-02300e8","series-title":"Clin Cancer Res","first-page":"2998","article-title":"A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2","volume":"7","author":"Pyo","year":"2001"},{"key":"b43-02300e8","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.22441","article-title":"Celecoxib inhibits meningioma tumor growth in a mouse xenograft model","volume":"109","author":"Ragel","year":"2007"},{"key":"b44-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3171\/jns.2005.103.3.0508","article-title":"Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application","volume":"103","author":"Ragel","year":"2005"},{"key":"b45-02300e8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3171\/jns.1997.86.5.0840","article-title":"Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea","volume":"86","author":"Schrell","year":"1997"},{"key":"b46-02300e8","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1158\/0008-5472.CAN-05-0220","article-title":"Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels","volume":"65","author":"Shin","year":"2005"},{"key":"b47-02300e8","series-title":"Nature","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992"},{"issue":"2 Suppl","key":"b48-02300e8","series-title":"Biomed Pharmacother","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1016\/S0753-3322(05)80044-7","article-title":"COX-2 inhibitors act as radiosensitizer in tumor treatment","volume":"59","author":"Sminia","year":"2005"},{"key":"b49-02300e8","series-title":"World J Gastroenterol","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.3748\/wjg.v12.i39.6355","article-title":"Expression of 5-lipoxygenase in human colorectal cancer","volume":"12","author":"Soumaoro","year":"2006"},{"key":"b50-02300e8","series-title":"Cell","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995"},{"key":"b51-02300e8","series-title":"World J Gastroenterol","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3748\/wjg.v9.i9.1990","article-title":"Role of COX-2 in carcino-genesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis","volume":"9","author":"Wu","year":"2003"},{"key":"b52-02300e8","series-title":"Neuron","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993"},{"key":"b53-02300e8","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L","article-title":"Recurrence of meningiomas","volume":"89","author":"Yamasaki","year":"2000"},{"key":"b54-02300e8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1074\/jbc.270.19.11463","article-title":"Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6","volume":"270","author":"Yan","year":"1995"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/23\/4\/foc-07_10_e8.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/23\/4\/foc-07_10_e8.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/23\/4\/foc-07_10_e8.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:52:14Z","timestamp":1780131134000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/23\/4\/foc-07_10_e8.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":108,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/foc-07\/10\/e8","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}